Controlling Diabetes to Prevent CVD

COMPOSITION

Gliclazide 80 mg

INDICATION

• Type 2 Diabetes
• Cardiovascular Disorders

 GLATIX-M-80 Tablets

• Sulfonylurea/ SUs (insulin secretagogues)
• The experts opined that among the SUs, gliclazide provides effective glycemic control, has a low risk of hypoglycemia, does not cause weight gain, has renal safety, and provides treatment durability.

• Inhibits the increased adhesiveness of Diabetic monocytes to endothelial cells & reduces the production of TNF-alpha.

• Regarded as a novel carrier in the construction of PVC-based La (III)-selective membrane.

• Improved glycemic control and aids in the prevention of both microvascular & macrovascular complications.

• Safe and potent drug especially in patients with Ischemic heart disease.